Novo Integrated Sciences, Inc. Share Price
Equities
NVOS
US67011T3005
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5425 USD | +4.53% | +5.63% | -33.92% |
Sales 2022 | 11.74M 979M | Sales 2023 | 12.57M 1.05B | Capitalization | 21.96M 1.83B |
---|---|---|---|---|---|
Net income 2022 | -32M -2.67B | Net income 2023 | -13M -1.08B | EV / Sales 2022 | 5.36 x |
Net Debt 2022 | 11.3M 942M | Net Debt 2023 | 4.06M 338M | EV / Sales 2023 | 2.07 x |
P/E ratio 2022 |
-1.48
x | P/E ratio 2023 |
-1.08
x | Employees | 179 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.18% |
1 day | +4.62% | ||
1 week | +5.63% | ||
Current month | +11.35% | ||
1 month | +12.11% | ||
3 months | -31.56% | ||
6 months | -79.10% | ||
Current year | -33.92% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 18/18/18 | |
Vivek Sethi
DFI | Director of Finance/CFO | 38 | 07/23/07 |
Robert Oliva
PSD | President | 60 | 15/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Pope
BRD | Director/Board Member | 43 | 26/21/26 |
Chief Operating Officer | 65 | 13/14/13 | |
Sarfaraz Ali
BRD | Director/Board Member | 42 | 30/22/30 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 0.5425 | +4.53% | 128 184 |
26/24/26 | 0.519 | -1.26% | 470,838 |
25/24/25 | 0.5256 | +0.11% | 521,135 |
24/24/24 | 0.525 | +1.94% | 536,411 |
23/24/23 | 0.515 | +0.27% | 1,480,471 |
Delayed Quote Nasdaq, April 29, 2024 at 09:25 pm IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.92% | 9.89M | |
-14.40% | 84.68B | |
+14.82% | 81.12B | |
+11.62% | 29.59B | |
-9.06% | 16.73B | |
-1.39% | 16.36B | |
-31.58% | 11.77B | |
+1.82% | 11.72B | |
+30.80% | 11.71B | |
-0.47% | 11.66B |
- Stock Market
- Equities
- NVOS Stock